G. Yılmaz Et Al. , "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes," European Journal of Biology , vol.1, no.1, pp.1-8, 2024
Yılmaz, G. Et Al. 2024. In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes. European Journal of Biology , vol.1, no.1 , 1-8.
Yılmaz, G., Çelik, S., Özel, A., & Akyüz, S., (2024). In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes. European Journal of Biology , vol.1, no.1, 1-8.
Yılmaz, GÖZDE Et Al. "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes," European Journal of Biology , vol.1, no.1, 1-8, 2024
Yılmaz, GÖZDE Et Al. "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes." European Journal of Biology , vol.1, no.1, pp.1-8, 2024
Yılmaz, G. Et Al. (2024) . "In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes." European Journal of Biology , vol.1, no.1, pp.1-8.
@article{article, author={GÖZDE YILMAZ Et Al. }, title={In Silico Evaluation of ERQ Bioactive Tripeptide as an Anticancer Agent and an Inhibitor of SARS-CoV-2 Enzymes}, journal={European Journal of Biology}, year=2024, pages={1-8} }